Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Michael Kleiner Shochat

Hillel Yaffe Medical Center, Hadera (Israel)

7 More presentations in this session

Presentation thumbnail

Risk of worsening heart failure and all-cause mortality following mRNA covid-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study

Ms C. Sindet-Pedersen (Hellerup, DK)

Abstract Slides

Presentation thumbnail

Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction

Miss K. Gryglewska-Wawrzak (Lodz, PL)

Abstract Slides

Presentation thumbnail

The impact of pre-existing chronic heart failure on the intensive care treatment and outcome of old intensive care patients suffering from COVID-19

Doctor R. Bruno (Duesseldorf, DE)

Abstract Slides

Presentation thumbnail

History of heart failure and chronic kidney disease and the risk for all-cause death after COVID-19 during the three first waves in comparison to influenza outbreaks in Sweden.

Doctor V. Ritsinger (Stockholm, SE)

Abstract Slides

Presentation thumbnail

Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure

Doctor M. Bergami (Bologna, IT)

Abstract Slides

Access the full session

Session thumbnail

Covid-19 and heart failure

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Session

Acute heart failure: what to watch for

Congress Session

Acute heart failure therapies: from clinical trials to clinical practice

Congress Session

Devices in acute heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources